AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 9%
#450 out of 5286 analysts
Average Return
+27.2%
Win Rate
42%39 out of 92
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Erasca IncERAS
+854.25%$1.53$14.60
2025-03-20 -
2026-03-20
Buy
Erasca IncERAS
+523.97%$1.46$9.11
2025-04-29 -
2026-04-29
Buy
Scholar Rock Holding CorpSRRK
+314.00%$8.07$33.41
2024-06-24 -
2025-06-24
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-11 -
2024-10-11
Buy
Zentalis Pharmaceuticals IncZNTL
+224.60%$1.26$4.09
2025-05-14 -
2026-05-14
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Novabridge BiosciencesNBP
1Buy$7.00+280.43%Reiterates
a year ago
Aura Biosciences IncAURA
1Buy$22.00N/AAssumes
a year ago
Zentalis Pharmaceuticals IncZNTL
1Buy$10.00N/AReiterates
a year ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00N/AMaintains
a year ago
Tscan Therapeutics IncTCRX
1Buy$10.00N/AMaintains
a year ago
Erasca IncERAS
10Buy$6.00N/AReiterates
a year ago
Foghorn Therapeutics IncFHTX
1Buy$13.00N/AReiterates
a year ago
Sutro Biopharma IncSTRO
1Hold$20.00N/AReiterates
a year ago
Protara Therapeutics IncTARA
1Buy$23.00N/AReiterates
a year ago
Cg Oncology IncCGON
13Buy$75.00N/AReiterates
a year ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00N/AReiterates
a year ago
Mural Oncology PLCMURA
5Buy$6.00N/AMaintains
a year ago
Werewolf Therapeutics IncHOWL
16Buy$15.00N/AReiterates
a year ago
Engene Therapeutics IncENGN
2Buy$25.00N/AReiterates
a year ago
Scholar Rock Holding CorpSRRK
13Buy$50.00N/AMaintains
2 years ago
Imagenebio IncIMA
11Buy$48.00N/AReiterates
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.